Q-Pharm

A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs

James McCarthy, Silvana Sekuloski, Paul Griffin et al. · PLoS ONE · 2011 · 172 citations · Full text

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin et al. · Human Vaccines & Immunotherapeutics · 2020 · 145 citations · Full text

Respiratory Virus Immunity, Viral Immunity, Immunology +19

Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study

E. Geoffrey Playford, Trent P. Munro, Stephen M. Mahler et al. · The Lancet Infectious Diseases · 2020 · 135 citations · Full text

Vaccination, Veterinary Vaccine, Human Monoclonal Antibody +5

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study

James McCarthy, Thomas Rückle, Elhadj Djeriou et al. · Malaria Journal · 2016 · 125 citations · Full text

Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study

James McCarthy, Julie Lotharius, Thomas Rückle et al. · The Lancet Infectious Diseases · 2017 · 124 citations · Full text